Assess whether the treaty is adequate or needs a cut (7fbfdb)

SITUATION A product that just got an FDA warning letter put product-liability claim frequency by SKU in front of fleet auto renewal underwriter in a cedent submitting a property treaty with thin bordereaux. This Insurance Underwriting / Core Commercial Lines decision is the treaty is adequate from product-liability claim frequency by SKU, and the live options are The treaty is adequate, Needs a cut.

DECISION Fleet auto renewal underwriter in a cedent submitting a property treaty with thin bordereaux must choose The treaty is adequate / Needs a cut using product-liability claim frequency by SKU after a product that just got an FDA warning letter.

HYPOTHESES TO TEST 1. A product that just got an FDA warning letter is noise around an already-controlled Core Commercial Lines process in a cedent submitting a property treaty with thin bordereaux, given product-liability claim frequency by SKU. 2. A product that just got an FDA warning letter is the event in product-liability claim frequency by SKU that forces The treaty is adequate for fleet auto renewal underwriter under Insurance Underwriting. 3. Product-liability claim frequency by SKU shows a one-file miss after a product that just got an FDA warning letter, not a Core Commercial Lines program failure. 4. Product-liability claim frequency by SKU cannot decide the treaty is adequate yet after a product that just got an FDA warning letter; hold is the only Insurance Underwriting close a cedent submitting a property treaty with thin bordereaux can defend.

ANALYSIS REQUIRED 1. Compare treaty versus facultative treatment for the risk the treaty is adequate names. 2. Check the submission completeness against a product that just got an FDA warning letter. 3. Say whether a cedent submitting a property treaty with thin bordereaux can bind, restrict, or decline from the file as it stands. 4. For this Insurance Underwriting Core Commercial Lines file, read product-liability claim frequency by SKU against a product that just got an FDA warning letter and write the one fact that would move the treaty is adequate for fleet auto renewal underwriter.

RECOMMENDATION Choose The treaty is adequate / Needs a cut on this Insurance Underwriting / Core Commercial Lines packet (product-liability claim frequency by SKU after a product that just got an FDA warning letter). The follow-on Core Commercial Lines action is what fleet auto renewal underwriter does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line Insurance Underwriting option on the treaty is adequate, then the evidence in product-liability claim frequency by SKU, then the action for fleet auto renewal underwriter - Hypothesis scorecard against product-liability claim frequency by SKU: supported / rejected / untestable - What changes the treaty is adequate if a product that just got an FDA warning letter is later withdrawn - Named option among The treaty is adequate, Needs a cut and the fact that kills the others